Fluoroquinolone-related adverse events resulting in health service use and costs: A systematic review

What Is Old Is New Again: Delafloxacin, a Modern Fluoroquinolone

(2017) Jonathan C. Cho et al.   PHARMACOTHERAPY

Epidemiology of Adverse Drug Reactions in Europe: A Review of Recent Observational Studies

(2015) Jacoline C. Bouvy et al.   DRUG SAFETY

Direct health care costs of hospital admissions due to adverse events in the Netherlands

(2014) Fabienne J. H. Magdelijns et al.   EUROPEAN JOURNAL OF PUBLIC HEALTH

Risk of Severe Dysglycemia Among Diabetic Patients Receiving Levofloxacin, Ciprofloxacin, or Moxifloxacin in Taiwan

(2013) Hsu-Wen Chou et al.   CLINICAL INFECTIOUS DISEASES

Risk of Acute Liver Injury Associated with the Use of Moxifloxacin and Other Oral Antimicrobials: A Retrospective, Population-Based Cohort Study

(2013) James A. Kaye et al.   PHARMACOTHERAPY

Clinical and economic burden of Clostridium difficile infection in Europe: a systematic review of healthcare-facility-acquired infection

(2012) P.N. Wiegand et al.   JOURNAL OF HOSPITAL INFECTION

Ciprofloxacin safety in paediatrics: a systematic review

(2011) A. Adefurin et al.   ARCHIVES OF DISEASE IN CHILDHOOD

Safety Profile of the Fluoroquinolones

(2010) Hans H. Liu   DRUG SAFETY

Severe Dysglycemia with the Fluoroquinolones: A Class Effect?

(2009) Sherrie L. Aspinall et al.   CLINICAL INFECTIOUS DISEASES